Is There A Cure For AVII's Volatility

AVI BioPharma (Nasdaq: AVII) is selling off approximately 7.3% today after, gaining 23% on Monday. AVI BioPharma (AVII) was called more than once a highly speculative stock, because of its drugs that treat rare and incurable diseases.

AVI BioPharma (AVII) has several drugs in the early stage trials. These drugs battle Duchenne muscular dystrophy, Ebola and Marburg, coronary-artery blockage and swine flu.

If you like risky investments than AVII is a right stock to consider buying.